

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | central nervous system myelination (GO:0022010) | 4.83454373 |
| 2 | axon ensheathment in central nervous system (GO:0032291) | 4.83454373 |
| 3 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.63767997 |
| 4 | axonemal dynein complex assembly (GO:0070286) | 4.63367479 |
| 5 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.10663102 |
| 6 | synaptic vesicle maturation (GO:0016188) | 3.97147531 |
| 7 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.93439617 |
| 8 | cerebral cortex neuron differentiation (GO:0021895) | 3.86268007 |
| 9 | glutamate secretion (GO:0014047) | 3.80834479 |
| 10 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.73477096 |
| 11 | sleep (GO:0030431) | 3.50617425 |
| 12 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.48383061 |
| 13 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.47870956 |
| 14 | neuronal action potential propagation (GO:0019227) | 3.44204674 |
| 15 | gamma-aminobutyric acid transport (GO:0015812) | 3.44191076 |
| 16 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.44037754 |
| 17 | urinary tract smooth muscle contraction (GO:0014848) | 3.42816527 |
| 18 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.32187091 |
| 19 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.31852159 |
| 20 | synaptic vesicle exocytosis (GO:0016079) | 3.31672515 |
| 21 | regulation of cilium movement (GO:0003352) | 3.27020474 |
| 22 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.22407636 |
| 23 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.21643273 |
| 24 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.18481851 |
| 25 | regulation of synapse structural plasticity (GO:0051823) | 3.18230382 |
| 26 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.15842207 |
| 27 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.15267737 |
| 28 | negative regulation of inclusion body assembly (GO:0090084) | 3.14483404 |
| 29 | negative regulation of oligodendrocyte differentiation (GO:0048715) | 3.11867755 |
| 30 | activation of protein kinase A activity (GO:0034199) | 3.09788339 |
| 31 | cellular potassium ion homeostasis (GO:0030007) | 3.07561452 |
| 32 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.03285782 |
| 33 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.01926469 |
| 34 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.01283506 |
| 35 | sodium ion export (GO:0071436) | 2.97845238 |
| 36 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.96543688 |
| 37 | detection of calcium ion (GO:0005513) | 2.95915774 |
| 38 | regulation of cell communication by electrical coupling (GO:0010649) | 2.93413013 |
| 39 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.92912788 |
| 40 | negative regulation of astrocyte differentiation (GO:0048712) | 2.91633227 |
| 41 | regulation of ARF protein signal transduction (GO:0032012) | 2.88341529 |
| 42 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.83309541 |
| 43 | L-amino acid import (GO:0043092) | 2.81118294 |
| 44 | neurotransmitter secretion (GO:0007269) | 2.79522129 |
| 45 | vocalization behavior (GO:0071625) | 2.75794432 |
| 46 | neuroblast proliferation (GO:0007405) | 2.74659660 |
| 47 | cell communication by electrical coupling (GO:0010644) | 2.70911682 |
| 48 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.70686997 |
| 49 | cardiac muscle hypertrophy (GO:0003300) | 2.68453496 |
| 50 | cilium movement (GO:0003341) | 2.68355634 |
| 51 | cardiac muscle contraction (GO:0060048) | 2.67528952 |
| 52 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.66686562 |
| 53 | muscle hypertrophy in response to stress (GO:0003299) | 2.66686562 |
| 54 | cardiac muscle adaptation (GO:0014887) | 2.66686562 |
| 55 | cGMP-mediated signaling (GO:0019934) | 2.62769514 |
| 56 | cerebellar granule cell differentiation (GO:0021707) | 2.62661293 |
| 57 | striated muscle hypertrophy (GO:0014897) | 2.61563633 |
| 58 | regulation of microtubule-based movement (GO:0060632) | 2.60553493 |
| 59 | regulation of synaptic vesicle transport (GO:1902803) | 2.60034186 |
| 60 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.58362870 |
| 61 | positive regulation of synapse maturation (GO:0090129) | 2.57814252 |
| 62 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.54420136 |
| 63 | regulation of synaptic plasticity (GO:0048167) | 2.54236718 |
| 64 | motile cilium assembly (GO:0044458) | 2.52889234 |
| 65 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.50838163 |
| 66 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.50253052 |
| 67 | artery smooth muscle contraction (GO:0014824) | 2.49697240 |
| 68 | SMAD protein complex assembly (GO:0007183) | 2.49531759 |
| 69 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.49525046 |
| 70 | signal complex assembly (GO:0007172) | 2.46573292 |
| 71 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.45972850 |
| 72 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.44297058 |
| 73 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.42422564 |
| 74 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.42422564 |
| 75 | membrane depolarization during action potential (GO:0086010) | 2.40972541 |
| 76 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.40135770 |
| 77 | potassium ion export (GO:0071435) | 2.39999581 |
| 78 | neuromuscular process controlling posture (GO:0050884) | 2.39507753 |
| 79 | muscle hypertrophy (GO:0014896) | 2.39418386 |
| 80 | regulation of actin filament-based movement (GO:1903115) | 2.37978918 |
| 81 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.37190001 |
| 82 | adenosine receptor signaling pathway (GO:0001973) | 2.36997174 |
| 83 | cell communication involved in cardiac conduction (GO:0086065) | 2.35197515 |
| 84 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.34914481 |
| 85 | vesicle docking (GO:0048278) | 2.33707074 |
| 86 | glutamate receptor signaling pathway (GO:0007215) | 2.33643173 |
| 87 | tonic smooth muscle contraction (GO:0014820) | 2.32931423 |
| 88 | vesicle docking involved in exocytosis (GO:0006904) | 2.32673095 |
| 89 | response to gravity (GO:0009629) | 2.29335791 |
| 90 | apical protein localization (GO:0045176) | 2.27799657 |
| 91 | amino acid import (GO:0043090) | 2.26587421 |
| 92 | histone H4-K12 acetylation (GO:0043983) | 2.26432582 |
| 93 | regulation of inclusion body assembly (GO:0090083) | 2.23982296 |
| 94 | epithelial cilium movement (GO:0003351) | 2.23598672 |
| 95 | long term synaptic depression (GO:0060292) | 2.23232035 |
| 96 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.22334688 |
| 97 | layer formation in cerebral cortex (GO:0021819) | 2.22174194 |
| 98 | cellular response to epinephrine stimulus (GO:0071872) | 2.21618185 |
| 99 | exploration behavior (GO:0035640) | 2.21540135 |
| 100 | brain morphogenesis (GO:0048854) | 2.20189941 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.62959903 |
| 2 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.61972343 |
| 3 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.52424479 |
| 4 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.40216557 |
| 5 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.29340199 |
| 6 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.11568201 |
| 7 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.05238472 |
| 8 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.03911353 |
| 9 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.01991173 |
| 10 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.98410787 |
| 11 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.93164467 |
| 12 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.88808584 |
| 13 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.81023151 |
| 14 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.80647451 |
| 15 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.70949022 |
| 16 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.63087280 |
| 17 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.62525592 |
| 18 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.62337981 |
| 19 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.61117771 |
| 20 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.60988239 |
| 21 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.57728940 |
| 22 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.57728940 |
| 23 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.54971872 |
| 24 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.52806542 |
| 25 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.51782496 |
| 26 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.49397857 |
| 27 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.49031275 |
| 28 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.44890918 |
| 29 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.36061479 |
| 30 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.35454186 |
| 31 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.32750499 |
| 32 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.32487330 |
| 33 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.25751137 |
| 34 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.25076076 |
| 35 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.24429002 |
| 36 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.23307763 |
| 37 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.21271399 |
| 38 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.18741829 |
| 39 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.11000656 |
| 40 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.10137399 |
| 41 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.09471382 |
| 42 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.09063959 |
| 43 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.07878775 |
| 44 | KDM2B_26808549_Chip-Seq_K562_Human | 1.07696888 |
| 45 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.07394330 |
| 46 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.06079472 |
| 47 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.03999837 |
| 48 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.03204097 |
| 49 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01160301 |
| 50 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.00020756 |
| 51 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.00003089 |
| 52 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.99194328 |
| 53 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.98939018 |
| 54 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.97794512 |
| 55 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.96777621 |
| 56 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.96455387 |
| 57 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.96064382 |
| 58 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.94988842 |
| 59 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.94539751 |
| 60 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94481767 |
| 61 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93754433 |
| 62 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.92701520 |
| 63 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.92701520 |
| 64 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.92623966 |
| 65 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.92078273 |
| 66 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.91300253 |
| 67 | TP53_16413492_ChIP-PET_HCT116_Human | 0.89882949 |
| 68 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.89818064 |
| 69 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.89214565 |
| 70 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.88415513 |
| 71 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.87023565 |
| 72 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.86733817 |
| 73 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.85980430 |
| 74 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.85045446 |
| 75 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.84896803 |
| 76 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.84228201 |
| 77 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.84228201 |
| 78 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.83804883 |
| 79 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.82950918 |
| 80 | CJUN_26792858_Chip-Seq_BT549_Human | 0.82763843 |
| 81 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.82377395 |
| 82 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.82035573 |
| 83 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.80112238 |
| 84 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.79493869 |
| 85 | GATA1_19941826_ChIP-Seq_K562_Human | 0.79206495 |
| 86 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.78980079 |
| 87 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.78405790 |
| 88 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.77723124 |
| 89 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.77559347 |
| 90 | AR_19668381_ChIP-Seq_PC3_Human | 0.76984697 |
| 91 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.76694372 |
| 92 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.76449067 |
| 93 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.76365379 |
| 94 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75190533 |
| 95 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.74645385 |
| 96 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.74608503 |
| 97 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.73161604 |
| 98 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.72718909 |
| 99 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.72352946 |
| 100 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.71432689 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.18501546 |
| 2 | MP0000751_myopathy | 2.95767489 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 2.70558611 |
| 4 | MP0002064_seizures | 2.54898928 |
| 5 | MP0004510_myositis | 2.52830042 |
| 6 | MP0009745_abnormal_behavioral_response | 2.49956412 |
| 7 | MP0004270_analgesia | 2.49938734 |
| 8 | MP0003329_amyloid_beta_deposits | 2.42846222 |
| 9 | MP0004084_abnormal_cardiac_muscle | 2.22904574 |
| 10 | MP0003075_altered_response_to | 2.05991550 |
| 11 | MP0002272_abnormal_nervous_system | 2.03406946 |
| 12 | MP0002063_abnormal_learning/memory/cond | 2.01935575 |
| 13 | MP0000604_amyloidosis | 1.99860218 |
| 14 | MP0004215_abnormal_myocardial_fiber | 1.95648220 |
| 15 | MP0002837_dystrophic_cardiac_calcinosis | 1.94273144 |
| 16 | MP0009046_muscle_twitch | 1.93011493 |
| 17 | MP0005423_abnormal_somatic_nervous | 1.87835076 |
| 18 | MP0002735_abnormal_chemical_nociception | 1.87804152 |
| 19 | MP0003136_yellow_coat_color | 1.87355978 |
| 20 | MP0004036_abnormal_muscle_relaxation | 1.86807958 |
| 21 | MP0009780_abnormal_chondrocyte_physiolo | 1.83591682 |
| 22 | MP0002734_abnormal_mechanical_nocicepti | 1.81987556 |
| 23 | MP0003880_abnormal_central_pattern | 1.80654749 |
| 24 | MP0002572_abnormal_emotion/affect_behav | 1.76790086 |
| 25 | MP0000749_muscle_degeneration | 1.74580102 |
| 26 | MP0001501_abnormal_sleep_pattern | 1.67614346 |
| 27 | MP0008569_lethality_at_weaning | 1.67476030 |
| 28 | MP0003690_abnormal_glial_cell | 1.64821199 |
| 29 | MP0003183_abnormal_peptide_metabolism | 1.63171042 |
| 30 | MP0001984_abnormal_olfaction | 1.62826411 |
| 31 | MP0001970_abnormal_pain_threshold | 1.61201424 |
| 32 | MP0003633_abnormal_nervous_system | 1.59396167 |
| 33 | MP0001486_abnormal_startle_reflex | 1.57853614 |
| 34 | MP0002733_abnormal_thermal_nociception | 1.53825565 |
| 35 | MP0003828_pulmonary_edema | 1.53637257 |
| 36 | MP0003879_abnormal_hair_cell | 1.53207805 |
| 37 | MP0002332_abnormal_exercise_endurance | 1.52388282 |
| 38 | MP0002972_abnormal_cardiac_muscle | 1.48664378 |
| 39 | MP0005623_abnormal_meninges_morphology | 1.47005781 |
| 40 | MP0000465_gastrointestinal_hemorrhage | 1.45683760 |
| 41 | MP0001968_abnormal_touch/_nociception | 1.45317104 |
| 42 | MP0006138_congestive_heart_failure | 1.42944588 |
| 43 | MP0005165_increased_susceptibility_to | 1.41665790 |
| 44 | MP0000343_altered_response_to | 1.41294754 |
| 45 | MP0005620_abnormal_muscle_contractility | 1.37637498 |
| 46 | MP0005330_cardiomyopathy | 1.31747561 |
| 47 | MP0003045_fibrosis | 1.30693650 |
| 48 | MP0003634_abnormal_glial_cell | 1.28568532 |
| 49 | MP0004484_altered_response_of | 1.27940193 |
| 50 | MP0005646_abnormal_pituitary_gland | 1.27551057 |
| 51 | MP0001440_abnormal_grooming_behavior | 1.25226538 |
| 52 | MP0001502_abnormal_circadian_rhythm | 1.24802882 |
| 53 | MP0002653_abnormal_ependyma_morphology | 1.24342787 |
| 54 | MP0004087_abnormal_muscle_fiber | 1.23691404 |
| 55 | MP0008004_abnormal_stomach_pH | 1.23363059 |
| 56 | MP0004233_abnormal_muscle_weight | 1.23084239 |
| 57 | MP0010368_abnormal_lymphatic_system | 1.19014792 |
| 58 | MP0002067_abnormal_sensory_capabilities | 1.18620837 |
| 59 | MP0005464_abnormal_platelet_physiology | 1.18081149 |
| 60 | MP0000920_abnormal_myelination | 1.17876144 |
| 61 | MP0003631_nervous_system_phenotype | 1.17721958 |
| 62 | MP0003172_abnormal_lysosome_physiology | 1.15548554 |
| 63 | MP0004130_abnormal_muscle_cell | 1.14395509 |
| 64 | MP0000569_abnormal_digit_pigmentation | 1.13154999 |
| 65 | MP0001851_eye_inflammation | 1.12236901 |
| 66 | MP0005058_abnormal_lysosome_morphology | 1.11151647 |
| 67 | MP0002896_abnormal_bone_mineralization | 1.10279045 |
| 68 | MP0000747_muscle_weakness | 1.06069110 |
| 69 | MP0005503_abnormal_tendon_morphology | 1.05904516 |
| 70 | MP0004145_abnormal_muscle_electrophysio | 1.01538923 |
| 71 | MP0002269_muscular_atrophy | 1.01029683 |
| 72 | MP0000759_abnormal_skeletal_muscle | 0.99913975 |
| 73 | MP0010678_abnormal_skin_adnexa | 0.99730186 |
| 74 | MP0008438_abnormal_cutaneous_collagen | 0.99288367 |
| 75 | MP0003137_abnormal_impulse_conducting | 0.97917217 |
| 76 | MP0002106_abnormal_muscle_physiology | 0.94510427 |
| 77 | MP0004085_abnormal_heartbeat | 0.93440767 |
| 78 | MP0002066_abnormal_motor_capabilities/c | 0.92464123 |
| 79 | MP0008874_decreased_physiological_sensi | 0.91429632 |
| 80 | MP0000750_abnormal_muscle_regeneration | 0.89884155 |
| 81 | MP0005410_abnormal_fertilization | 0.89809636 |
| 82 | MP0005166_decreased_susceptibility_to | 0.89349576 |
| 83 | MP0003646_muscle_fatigue | 0.86112522 |
| 84 | MP0002736_abnormal_nociception_after | 0.84612884 |
| 85 | MP0005595_abnormal_vascular_smooth | 0.82733666 |
| 86 | MP0001765_abnormal_ion_homeostasis | 0.82527486 |
| 87 | MP0010630_abnormal_cardiac_muscle | 0.81487108 |
| 88 | MP0005385_cardiovascular_system_phenoty | 0.80766602 |
| 89 | MP0001544_abnormal_cardiovascular_syste | 0.80766602 |
| 90 | MP0002229_neurodegeneration | 0.77900502 |
| 91 | MP0004885_abnormal_endolymph | 0.77823639 |
| 92 | MP0009384_cardiac_valve_regurgitation | 0.77562274 |
| 93 | MP0005670_abnormal_white_adipose | 0.77128049 |
| 94 | MP0002971_abnormal_brown_adipose | 0.75329386 |
| 95 | MP0005369_muscle_phenotype | 0.74888116 |
| 96 | MP0005535_abnormal_body_temperature | 0.74292113 |
| 97 | MP0005666_abnormal_adipose_tissue | 0.74209431 |
| 98 | MP0010234_abnormal_vibrissa_follicle | 0.74024105 |
| 99 | MP0002882_abnormal_neuron_morphology | 0.73711805 |
| 100 | MP0004811_abnormal_neuron_physiology | 0.73345429 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 5.51168208 |
| 2 | Focal motor seizures (HP:0011153) | 5.17877846 |
| 3 | Abnormal respiratory epithelium morphology (HP:0012253) | 4.85943832 |
| 4 | Abnormal respiratory motile cilium morphology (HP:0005938) | 4.85943832 |
| 5 | Atonic seizures (HP:0010819) | 4.79557288 |
| 6 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 4.79546367 |
| 7 | Absent/shortened dynein arms (HP:0200106) | 4.79546367 |
| 8 | Action tremor (HP:0002345) | 3.93439241 |
| 9 | Abnormal respiratory motile cilium physiology (HP:0012261) | 3.82167165 |
| 10 | Muscle fiber splitting (HP:0003555) | 3.76014403 |
| 11 | Abnormal ciliary motility (HP:0012262) | 3.72544168 |
| 12 | Febrile seizures (HP:0002373) | 3.48183450 |
| 13 | Focal seizures (HP:0007359) | 3.38953906 |
| 14 | Absence seizures (HP:0002121) | 3.24535609 |
| 15 | Rhinitis (HP:0012384) | 3.20669983 |
| 16 | Hemiplegia (HP:0002301) | 3.15796218 |
| 17 | Sudden death (HP:0001699) | 3.15382018 |
| 18 | Hyporeflexia of lower limbs (HP:0002600) | 2.98068338 |
| 19 | Neurofibrillary tangles (HP:0002185) | 2.96729702 |
| 20 | Generalized tonic-clonic seizures (HP:0002069) | 2.94497707 |
| 21 | Myokymia (HP:0002411) | 2.92504132 |
| 22 | Progressive cerebellar ataxia (HP:0002073) | 2.79930785 |
| 23 | Nasal polyposis (HP:0100582) | 2.77704860 |
| 24 | Bundle branch block (HP:0011710) | 2.76270718 |
| 25 | Exercise-induced myalgia (HP:0003738) | 2.75852096 |
| 26 | Supranuclear gaze palsy (HP:0000605) | 2.75615396 |
| 27 | Papilledema (HP:0001085) | 2.71064930 |
| 28 | Abnormality of glycolipid metabolism (HP:0010969) | 2.70523631 |
| 29 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.70523631 |
| 30 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.70523631 |
| 31 | Dialeptic seizures (HP:0011146) | 2.67831562 |
| 32 | Diplopia (HP:0000651) | 2.64063963 |
| 33 | Abnormality of binocular vision (HP:0011514) | 2.64063963 |
| 34 | Abnormality of the nasal mucosa (HP:0000433) | 2.58863753 |
| 35 | Ankle clonus (HP:0011448) | 2.55336140 |
| 36 | Distal lower limb muscle weakness (HP:0009053) | 2.52232934 |
| 37 | Mutism (HP:0002300) | 2.50828135 |
| 38 | Hemiparesis (HP:0001269) | 2.49956952 |
| 39 | Asymmetric septal hypertrophy (HP:0001670) | 2.47453660 |
| 40 | Truncal ataxia (HP:0002078) | 2.47335041 |
| 41 | Cerebral inclusion bodies (HP:0100314) | 2.46237708 |
| 42 | Syncope (HP:0001279) | 2.39512742 |
| 43 | EMG: myopathic abnormalities (HP:0003458) | 2.29979988 |
| 44 | Atrial fibrillation (HP:0005110) | 2.26768319 |
| 45 | Bronchiectasis (HP:0002110) | 2.23633147 |
| 46 | Diminished motivation (HP:0000745) | 2.22157518 |
| 47 | Tubulointerstitial nephritis (HP:0001970) | 2.22042016 |
| 48 | Primary atrial arrhythmia (HP:0001692) | 2.21193239 |
| 49 | Rimmed vacuoles (HP:0003805) | 2.21047624 |
| 50 | Apathy (HP:0000741) | 2.20021219 |
| 51 | Type 1 muscle fiber predominance (HP:0003803) | 2.15805418 |
| 52 | Purpura (HP:0000979) | 2.12859765 |
| 53 | Epileptic encephalopathy (HP:0200134) | 2.10560905 |
| 54 | Abnormality of dentin (HP:0010299) | 2.10300841 |
| 55 | Supraventricular tachycardia (HP:0004755) | 2.08623145 |
| 56 | Muscle fiber inclusion bodies (HP:0100299) | 2.08070505 |
| 57 | Lower limb muscle weakness (HP:0007340) | 2.07461826 |
| 58 | Delusions (HP:0000746) | 2.06318669 |
| 59 | Chronic bronchitis (HP:0004469) | 2.05732152 |
| 60 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.04169712 |
| 61 | Nemaline bodies (HP:0003798) | 2.02342745 |
| 62 | Abnormality of the vocal cords (HP:0008777) | 2.02268266 |
| 63 | Abnormality of the periventricular white matter (HP:0002518) | 2.01469753 |
| 64 | Status epilepticus (HP:0002133) | 2.00893803 |
| 65 | Supraventricular arrhythmia (HP:0005115) | 2.00683020 |
| 66 | Ventricular fibrillation (HP:0001663) | 1.99615009 |
| 67 | Increased variability in muscle fiber diameter (HP:0003557) | 1.98274451 |
| 68 | Ventricular arrhythmia (HP:0004308) | 1.95205644 |
| 69 | Abnormality of the calf musculature (HP:0001430) | 1.95099180 |
| 70 | Obstructive sleep apnea (HP:0002870) | 1.93846004 |
| 71 | Dysostosis multiplex (HP:0000943) | 1.91121112 |
| 72 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.90815745 |
| 73 | Rapidly progressive (HP:0003678) | 1.89355611 |
| 74 | Neuronal loss in central nervous system (HP:0002529) | 1.86745101 |
| 75 | Difficulty climbing stairs (HP:0003551) | 1.86561519 |
| 76 | Postural instability (HP:0002172) | 1.83914827 |
| 77 | Rigidity (HP:0002063) | 1.83745209 |
| 78 | Broad distal phalanx of finger (HP:0009836) | 1.82460485 |
| 79 | Prolonged bleeding time (HP:0003010) | 1.81494019 |
| 80 | Amyotrophic lateral sclerosis (HP:0007354) | 1.80929615 |
| 81 | Atelectasis (HP:0100750) | 1.79780310 |
| 82 | Distal arthrogryposis (HP:0005684) | 1.78651005 |
| 83 | EMG: neuropathic changes (HP:0003445) | 1.77754689 |
| 84 | Depression (HP:0000716) | 1.77372759 |
| 85 | Abnormal EKG (HP:0003115) | 1.75563457 |
| 86 | Foot dorsiflexor weakness (HP:0009027) | 1.74583129 |
| 87 | Intention tremor (HP:0002080) | 1.74039648 |
| 88 | Increased mean platelet volume (HP:0011877) | 1.72926512 |
| 89 | Abnormal atrioventricular conduction (HP:0005150) | 1.72095804 |
| 90 | Menorrhagia (HP:0000132) | 1.71278667 |
| 91 | Bulbar palsy (HP:0001283) | 1.70957576 |
| 92 | Heart block (HP:0012722) | 1.70506421 |
| 93 | Increased connective tissue (HP:0009025) | 1.69685656 |
| 94 | Axonal loss (HP:0003447) | 1.69180083 |
| 95 | Ventricular tachycardia (HP:0004756) | 1.69145635 |
| 96 | Lower limb amyotrophy (HP:0007210) | 1.69105267 |
| 97 | Lipoatrophy (HP:0100578) | 1.66239750 |
| 98 | Atrioventricular block (HP:0001678) | 1.65833850 |
| 99 | Nuclear cataract (HP:0100018) | 1.65048458 |
| 100 | Abnormal platelet volume (HP:0011876) | 1.62875358 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PNCK | 4.19496429 |
| 2 | DAPK2 | 2.92497187 |
| 3 | MAPK15 | 2.88186562 |
| 4 | EPHA4 | 2.37303873 |
| 5 | MARK1 | 2.25161524 |
| 6 | CAMKK1 | 2.07851699 |
| 7 | PHKG1 | 1.98696422 |
| 8 | PHKG2 | 1.98696422 |
| 9 | BLK | 1.88686372 |
| 10 | PAK6 | 1.88671185 |
| 11 | CAMKK2 | 1.86972204 |
| 12 | NTRK3 | 1.85927818 |
| 13 | ARAF | 1.85149177 |
| 14 | MAP3K13 | 1.76873732 |
| 15 | PTK2B | 1.76858583 |
| 16 | TTN | 1.71192525 |
| 17 | MARK2 | 1.66728477 |
| 18 | WNK1 | 1.63701920 |
| 19 | OBSCN | 1.60324750 |
| 20 | MAPK12 | 1.59771398 |
| 21 | PRPF4B | 1.50954412 |
| 22 | RIPK4 | 1.36325761 |
| 23 | NTRK1 | 1.27281805 |
| 24 | CAMK1 | 1.25173530 |
| 25 | MYLK | 1.22695239 |
| 26 | GRK7 | 1.22057028 |
| 27 | PINK1 | 1.20207235 |
| 28 | RIPK1 | 1.11654891 |
| 29 | PDPK1 | 1.10688131 |
| 30 | STK39 | 1.10048506 |
| 31 | MAP3K7 | 1.08434392 |
| 32 | STK38 | 1.07202139 |
| 33 | WNK4 | 1.06660967 |
| 34 | TESK1 | 1.04433735 |
| 35 | UHMK1 | 1.04320118 |
| 36 | CAMK2A | 1.04205501 |
| 37 | NEK9 | 1.01780453 |
| 38 | PKN1 | 0.99698326 |
| 39 | PDK1 | 0.98789196 |
| 40 | MOS | 0.97051855 |
| 41 | CAMK2B | 0.95633607 |
| 42 | KSR2 | 0.95235540 |
| 43 | MAPK7 | 0.94477431 |
| 44 | PRKCG | 0.94397427 |
| 45 | BMX | 0.92870063 |
| 46 | CDC42BPA | 0.90566620 |
| 47 | TAOK1 | 0.90210114 |
| 48 | GRK5 | 0.89858427 |
| 49 | PRKD3 | 0.89044738 |
| 50 | CDK5 | 0.88079374 |
| 51 | NTRK2 | 0.82913269 |
| 52 | MINK1 | 0.81956699 |
| 53 | ROCK1 | 0.81881084 |
| 54 | CAMK2G | 0.80860336 |
| 55 | TRPM7 | 0.80774544 |
| 56 | CAMK4 | 0.79661829 |
| 57 | TRIB3 | 0.79484014 |
| 58 | CAMK2D | 0.76394901 |
| 59 | LIMK1 | 0.76372210 |
| 60 | MAP2K4 | 0.76290103 |
| 61 | MAP3K9 | 0.76055454 |
| 62 | PLK2 | 0.75681592 |
| 63 | TBK1 | 0.75043864 |
| 64 | DDR2 | 0.74850912 |
| 65 | EPHB1 | 0.73659285 |
| 66 | LATS2 | 0.72743576 |
| 67 | DAPK1 | 0.70129608 |
| 68 | SGK1 | 0.69409585 |
| 69 | PRKCE | 0.67831754 |
| 70 | CDK19 | 0.65536157 |
| 71 | DAPK3 | 0.65408189 |
| 72 | CASK | 0.65160213 |
| 73 | CCNB1 | 0.65043539 |
| 74 | PRKCQ | 0.64585424 |
| 75 | DYRK1A | 0.64076610 |
| 76 | ROCK2 | 0.62889408 |
| 77 | PDGFRB | 0.62586512 |
| 78 | MAP3K11 | 0.61819190 |
| 79 | SIK2 | 0.61192794 |
| 80 | BMPR2 | 0.60064685 |
| 81 | TAOK2 | 0.60003184 |
| 82 | MAP2K6 | 0.59829112 |
| 83 | PRKD1 | 0.58676129 |
| 84 | MAP2K3 | 0.58512144 |
| 85 | MAPK10 | 0.58425354 |
| 86 | PRKD2 | 0.57450127 |
| 87 | STK11 | 0.57014272 |
| 88 | MET | 0.55048671 |
| 89 | ZAP70 | 0.54357197 |
| 90 | FGR | 0.52898329 |
| 91 | MAP3K12 | 0.52697399 |
| 92 | DMPK | 0.51980310 |
| 93 | MAP3K1 | 0.51502898 |
| 94 | IRAK2 | 0.51499849 |
| 95 | DYRK1B | 0.50934851 |
| 96 | MAP3K5 | 0.50811921 |
| 97 | PRKCH | 0.49723652 |
| 98 | MAP2K7 | 0.49032484 |
| 99 | PRKG1 | 0.48014805 |
| 100 | TGFBR2 | 0.47463678 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 2.46443953 |
| 2 | GABAergic synapse_Homo sapiens_hsa04727 | 2.18376312 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.10231691 |
| 4 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.09186116 |
| 5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.09026676 |
| 6 | Long-term potentiation_Homo sapiens_hsa04720 | 1.94336192 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 1.86746509 |
| 8 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.85183681 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 1.80220399 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.76209664 |
| 11 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.74163597 |
| 12 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.69972371 |
| 13 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.66664673 |
| 14 | Renin secretion_Homo sapiens_hsa04924 | 1.62922314 |
| 15 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.60885907 |
| 16 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.58569552 |
| 17 | Insulin secretion_Homo sapiens_hsa04911 | 1.55095214 |
| 18 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.54398272 |
| 19 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.51226044 |
| 20 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.50419328 |
| 21 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.47899468 |
| 22 | Cocaine addiction_Homo sapiens_hsa05030 | 1.47656461 |
| 23 | Salivary secretion_Homo sapiens_hsa04970 | 1.43323295 |
| 24 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.39947664 |
| 25 | Circadian rhythm_Homo sapiens_hsa04710 | 1.39933537 |
| 26 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.34560691 |
| 27 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.29299608 |
| 28 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.26416508 |
| 29 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.24116060 |
| 30 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.24106942 |
| 31 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.24095364 |
| 32 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.24048804 |
| 33 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.16669129 |
| 34 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.16174392 |
| 35 | Gap junction_Homo sapiens_hsa04540 | 1.13399377 |
| 36 | Platelet activation_Homo sapiens_hsa04611 | 1.12448772 |
| 37 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.11690510 |
| 38 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.08373807 |
| 39 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.08151767 |
| 40 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.03623503 |
| 41 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.98290932 |
| 42 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.94974631 |
| 43 | Lysosome_Homo sapiens_hsa04142 | 0.93254335 |
| 44 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.90853876 |
| 45 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.90676518 |
| 46 | Taste transduction_Homo sapiens_hsa04742 | 0.90538021 |
| 47 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.89603671 |
| 48 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.89156809 |
| 49 | Olfactory transduction_Homo sapiens_hsa04740 | 0.84108245 |
| 50 | Amoebiasis_Homo sapiens_hsa05146 | 0.83141931 |
| 51 | Glioma_Homo sapiens_hsa05214 | 0.80699013 |
| 52 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.80638103 |
| 53 | Focal adhesion_Homo sapiens_hsa04510 | 0.79856989 |
| 54 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.75800825 |
| 55 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.75403399 |
| 56 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.73566355 |
| 57 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.72345009 |
| 58 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.71722690 |
| 59 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.71603239 |
| 60 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.70367793 |
| 61 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.69506164 |
| 62 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.68588449 |
| 63 | Endocytosis_Homo sapiens_hsa04144 | 0.67930803 |
| 64 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.67029351 |
| 65 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.66830832 |
| 66 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.65687829 |
| 67 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.63890462 |
| 68 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.62720159 |
| 69 | Prion diseases_Homo sapiens_hsa05020 | 0.62671736 |
| 70 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.62621796 |
| 71 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.61630001 |
| 72 | Melanogenesis_Homo sapiens_hsa04916 | 0.60224763 |
| 73 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.59800473 |
| 74 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.58201247 |
| 75 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.57529448 |
| 76 | Other glycan degradation_Homo sapiens_hsa00511 | 0.56990052 |
| 77 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.56193611 |
| 78 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.55324221 |
| 79 | Long-term depression_Homo sapiens_hsa04730 | 0.55067656 |
| 80 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.54505119 |
| 81 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.54478856 |
| 82 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.54399580 |
| 83 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.53308752 |
| 84 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.52707083 |
| 85 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.51666351 |
| 86 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.49597725 |
| 87 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.49562758 |
| 88 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.48855670 |
| 89 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.47866898 |
| 90 | Bile secretion_Homo sapiens_hsa04976 | 0.47670502 |
| 91 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.47461342 |
| 92 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.47275039 |
| 93 | Phagosome_Homo sapiens_hsa04145 | 0.47265488 |
| 94 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.46997727 |
| 95 | Axon guidance_Homo sapiens_hsa04360 | 0.46177481 |
| 96 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.45776646 |
| 97 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.45684263 |
| 98 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.45622840 |
| 99 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.45318345 |
| 100 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.45186776 |

